These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16517609)

  • 1. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.
    Choi J; Sullards MC; Olzmann JA; Rees HD; Weintraub ST; Bostwick DE; Gearing M; Levey AI; Chin LS; Li L
    J Biol Chem; 2006 Apr; 281(16):10816-24. PubMed ID: 16517609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.
    Choi J; Levey AI; Weintraub ST; Rees HD; Gearing M; Chin LS; Li L
    J Biol Chem; 2004 Mar; 279(13):13256-64. PubMed ID: 14722078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
    Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ
    Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.
    Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.
    Saito Y; Hamakubo T; Yoshida Y; Ogawa Y; Hara Y; Fujimura H; Imai Y; Iwanari H; Mochizuki Y; Shichiri M; Nishio K; Kinumi T; Noguchi N; Kodama T; Niki E
    Neurosci Lett; 2009 Nov; 465(1):1-5. PubMed ID: 19733211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential DJ-1 gene expression in Parkinson's disease.
    Kumaran R; Vandrovcova J; Luk C; Sharma S; Renton A; Wood NW; Hardy JA; Lees AJ; Bandopadhyay R
    Neurobiol Dis; 2009 Nov; 36(2):393-400. PubMed ID: 19716892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases.
    Choi J; Rees HD; Weintraub ST; Levey AI; Chin LS; Li L
    J Biol Chem; 2005 Mar; 280(12):11648-55. PubMed ID: 15659387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.
    Lin X; Cook TJ; Zabetian CP; Leverenz JB; Peskind ER; Hu SC; Cain KC; Pan C; Edgar JS; Goodlett DR; Racette BA; Checkoway H; Montine TJ; Shi M; Zhang J
    Sci Rep; 2012; 2():954. PubMed ID: 23233873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized.
    Terracciano C; Nogalska A; Engel WK; Wojcik S; Askanas V
    Free Radic Biol Med; 2008 Sep; 45(6):773-9. PubMed ID: 18601999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fat diet induced isoform changes of the Parkinson's disease protein DJ-1.
    Poschmann G; Seyfarth K; Besong Agbo D; Klafki HW; Rozman J; Wurst W; Wiltfang J; Meyer HE; Klingenspor M; Stühler K
    J Proteome Res; 2014 May; 13(5):2339-51. PubMed ID: 24646099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of oxidized DJ-1 in human and mouse brains.
    Saito Y; Miyasaka T; Hatsuta H; Takahashi-Niki K; Hayashi K; Mita Y; Kusano-Arai O; Iwanari H; Ariga H; Hamakubo T; Yoshida Y; Niki E; Murayama S; Ihara Y; Noguchi N
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):714-28. PubMed ID: 24918637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
    Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
    J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.
    Choi MS; Nakamura T; Cho SJ; Han X; Holland EA; Qu J; Petsko GA; Yates JR; Liddington RC; Lipton SA
    J Neurosci; 2014 Nov; 34(45):15123-31. PubMed ID: 25378175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.
    Zhou W; Freed CR
    J Biol Chem; 2005 Dec; 280(52):43150-8. PubMed ID: 16227205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1.
    Ishikawa S; Taira T; Niki T; Takahashi-Niki K; Maita C; Maita H; Ariga H; Iguchi-Ariga SM
    J Biol Chem; 2009 Oct; 284(42):28832-44. PubMed ID: 19703902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
    Ooe H; Iguchi-Ariga SM; Ariga H
    Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.
    Shendelman S; Jonason A; Martinat C; Leete T; Abeliovich A
    PLoS Biol; 2004 Nov; 2(11):e362. PubMed ID: 15502874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
    Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
    Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease.
    Blackinton J; Kumaran R; van der Brug MP; Ahmad R; Olson L; Galter D; Lees A; Bandopadhyay R; Cookson MR
    Neurosci Lett; 2009 Mar; 452(1):8-11. PubMed ID: 19146923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.